Takeda seeks global reach with $12 billion Nycomed bid

some delays it won U.S. approval in March where Forest Laboratories has the marketing rights. In Europe, Merck & Co has marketing rights. Another of Nycomed's top products is pantoprazole for heartburn, a field Takeda knows from its own Prevacid, a...